Description If there is a cure-all for cancer, Panacea Pharmaceuticals is out to find it. The biotech focuses on new therapies and diagnostics for cancer and central nervous system diseases, including Alzheimer's and Parkinson's diseases. Its cancer research and development focuses on stopping an enzyme often expressed by aggressive tumors. Panacea looks to treat the underlying causes of Alzheimer's and Parkinson's rather than slow their progress. The company has three products in preclincial development that include treatments for liver and bile duct cancer, and ischemic stroke. Panacea, founded in 1999, performs in-house research and development at its facility in Gaithersburg, Maryland.